Cargando…
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
BACKGROUND: To determine the kinetics and persistence of immune responses following the Sinopharm/BBIBP‐CorV, we investigated immune responses in a cohort of Sri Lankan individuals. METHODS: SARS‐CoV‐2 specific total antibodies were measured in 20–39 years (n = 61), 40–59 years (n = 120) and those &...
Autores principales: | Jeewandara, Chandima, Aberathna, Inoka Sepali, Pushpakumara, Pradeep Darshana, Kamaladasa, Achala, Guruge, Dinuka, Wijesinghe, Ayesha, Gunasekera, Banuri, Ramu, Shyrar Tanussiya, Kuruppu, Heshan, Ranasinghe, Thushali, Dayarathna, Shashika, Dissanayake, Osanda, Gamalath, Nayanathara, Ekanayake, Dinithi, Jayamali, Jeewantha, Jayathilaka, Deshni, Dissanayake, Madushika, Jayadas, Tibutius Thanesh, Mudunkotuwa, Anushika, Somathilake, Gayasha, Harvie, Michael, Nimasha, Thashmi, Danasekara, Saubhagya, Wijayamuni, Ruwan, Schimanski, Lisa, Rijal, Pramila, Tan, Tiong K., Dong, Tao, Townsend, Alain, Ogg, Graham S., Malavige, Gathsaurie Neelika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091995/ https://www.ncbi.nlm.nih.gov/pubmed/35634958 http://dx.doi.org/10.1002/iid3.621 |
Ejemplares similares
-
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2021) -
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2021) -
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
por: Jeewandara, Chandima, et al.
Publicado: (2022) -
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka
por: Jeewandara, Chandima, et al.
Publicado: (2022) -
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
por: Jeewandara, Chandima, et al.
Publicado: (2022)